DOI QR코드

DOI QR Code

The Impact of Metabolic and Bariatric Surgery on Morbidly Obese Patients with Type 2 DM

제2형 당뇨병을 동반한 국내 고도비만 환자에서 대사비만 수술의 효과

  • Lee, Hong-Chan (Department of Surgery, Yeouido St. Mary's Hospital, The Catholic University of Korea) ;
  • Kim, Mi-Kyoung (Department of Internal Medicine, Yeouido St. Mary's Hospital, The Catholic University of Korea) ;
  • Kwon, Hyuk-Sang (Department of Internal Medicine, Yeouido St. Mary's Hospital, The Catholic University of Korea) ;
  • Song, Ki-Ho (Department of Internal Medicine, Yeouido St. Mary's Hospital, The Catholic University of Korea) ;
  • Kim, Eung-Kook (Department of Surgery, Yeouido St. Mary's Hospital, The Catholic University of Korea)
  • 이홍찬 (가톨릭대학교 여의도성모병원 외과) ;
  • 김미경 (가톨릭대학교 여의도성모병원 내과) ;
  • 권혁상 (가톨릭대학교 여의도성모병원 내과) ;
  • 송기호 (가톨릭대학교 여의도성모병원 내과) ;
  • 김응국 (가톨릭대학교 여의도성모병원 외과)
  • Received : 2010.01.13
  • Accepted : 2010.03.23
  • Published : 2010.07.01

Abstract

Purpose: Laparoscopic Roux-en-Y gastric bypass (LRYGB) and laparoscopic adjustable gastric banding (LAGB) are the most effective intervention and cure in achieving sustained weight loss in the morbidly obese with co-morbities, especially in type 2 diabetes mellitus (DM). Currently, there are few data in the literature presenting early diabetic outcomes between the 2 major bariatric surgeries in Korea. The aim of this study is to observe weight loss, improvement of type 2 DM after LRYGB and LAGB. Methods: 33 retrospective data were obtained from diabetic subjects undergoing LRYGB (n=53) and LAGB (n=77). These measurements included age, sex, body mass index (BMI), pre-operative diabetic duration, post-operative diabetic at follow-up visit after surgery. Paired t-test, and SPSS12.0 were used for statistical analysis. Results: 33 morbidly obese patients with type 2 DM who had both procedures complain of general weakness. Most patients were taking oral medications or insulin and tired of them. Pre and post-op 12 months of percent of excess weight loss (%EWL), fetal bovine serum (FBS), hemoglobin A1c (HbA1C) presented at 0%, 185.6 mg/dl, 8.7% and 70.6%, 123.4 mg/dl, 6.6% in patients who had LRYGB (P<0.05). Pre and post-op 12 months of %EWL, FBS, HbA1C presented at 0%, 180.6 mg/dl, 8.4% and 32.8%, 136.5 mg/dl, 6.8% in patients who had LAGB (P<0.05). Rate of discontinuance or decreasing for treatment of type 2 DM after surgery showed 94% for LRYGB versus 80% for LAGB, and unchanged rates were 6% versus 20%, respectively. Conclusion: This study showed LRYGB and LAGB are quite satisfactory and promising bariatric procedures with significant weight loss and improvement of type 2 DM in Koreans. LRYGB is significantly associated with more weight loss, more diabetic outcome than LAGB. Clinical experiences in Korea with both procedures are limited and a larger number of cases are need, but the recent data shows promising results that are comparable to the international experience.

Keywords

References

  1. Cummings S, Apovian CM, Khaodhiar L. Obesity surgery: evidence for diabetes prevention/management. J Am Diet Assoc 2008;108:S40-4. https://doi.org/10.1016/j.jada.2008.01.017
  2. Schauer PR, Burguera B, Ikramuddin S, Cottam D, Gourash W, Hamad G, et al. Effect of laparoscopic Roux-en Y gastric bypass on type 2 diabetes mellitus. Ann Surg 2003;238:467-84; discussion 84-5.
  3. Sugerman HJ, Wolfe LG, Sica DA, Clore JN. Diabetes and hypertension in severe obesity and effects of gastric bypassinduced weight loss. Ann Surg 2003;237:751-6; discussion 7-8.
  4. Guidone C, Manco M, Valera-Mora E, Iaconelli A, Gniuli D, Mari A, et al. Mechanisms of recovery from type 2 diabetes after malabsorptive bariatric surgery. Diabetes 2006;55:2025-31. https://doi.org/10.2337/db06-0068
  5. Rosa G, Mingrone G, Manco M, Euthine V, Gniuli D, Calvani R, et al. Molecular mechanisms of diabetes reversibility after bariatric surgery. Int J Obes (Lond) 2007;31:1429-36. https://doi.org/10.1038/sj.ijo.0803630
  6. Yoon KH, Lee JH, Kim JW, Cho JH, Choi YH, Ko SH, et al. Epidemic obesity and type 2 diabetes in Asia. Lancet 2006;368:1681-8. https://doi.org/10.1016/S0140-6736(06)69703-1
  7. Kim E, Kim D, Lee S, Lee H. Minimal-scar laparoscopic adjustable gastric Banding (LAGB). Obes Surg 2009;19:500-3. https://doi.org/10.1007/s11695-008-9713-6
  8. Lee H, Kim D, Lee S, Nam K, Kim E. Initial evaluation of laparoscopic Roux-en-Y gastric bypass and adjustable gastric banding in Korea: a single institution study. Obes Surg. Forthcoming 2008.
  9. Flier J, Maratos-Flier E. Energy homeostasis and body weight. Curr Biol 2000;10:R215-7. https://doi.org/10.1016/S0960-9822(00)00393-6
  10. Kahn BB, Flier JS. Obesity and insulin resistance. J Clin Invest 2000;106:473-81. https://doi.org/10.1172/JCI10842
  11. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998; 352:837-53. https://doi.org/10.1016/S0140-6736(98)07019-6
  12. Min HK. Non-insulin-dependent diabetes mellitus (NIDDM) in Korea. Diabet Med 1996;13:S13-5.

Cited by

  1. The surgical treatment for type 2 diabetes mellitus vol.54, pp.2, 2010, https://doi.org/10.5124/jkma.2011.54.2.181
  2. Improvement of Type 2 Diabetes after Bariatric Surgery in a Patient with Severe Obesity vol.12, pp.1, 2010, https://doi.org/10.4093/jkd.2011.12.1.53
  3. 고도비만환자에서 베리아트릭 수술 (Bariatric Surgery) 후 영양교육이 체중감량에 미치는 효과 vol.48, pp.1, 2015, https://doi.org/10.4163/jnh.2015.48.1.30